Free Trial

Sunshine Biopharma (SBFMW) SEC Filings & 10K Form

Sunshine Biopharma logo
$0.28 +0.08 (+38.89%)
Closing price 04/2/2025 03:59 PM Eastern
Extended Trading
$0.30 +0.02 (+7.14%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Sunshine Biopharma SEC Filings

DateFilerForm TypeView
04/02/2025
9:50 AM
Sunshine Biopharma Inc. (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
4:05 PM
Sunshine Biopharma Inc. (Filer)
Sunshine Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2025
3:05 PM
Sunshine Biopharma Inc. (Filer)
Sunshine Biopharma (Filer)
Form NT 10-K
02/14/2025
3:43 PM
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Sunshine Biopharma Inc. (Subject)
Sunshine Biopharma (Subject)
Form SCHEDULE 13G/A
01/21/2025
7:20 AM
Roy Michel (Reporting)
Sunshine Biopharma Inc. (Issuer)
Sunshine Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/15/2025
11:15 PM
Sunshine Biopharma Inc. (Filer)
Sunshine Biopharma (Filer)
Form EFFECT
01/15/2025
7:30 AM
Sunshine Biopharma Inc. (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
10:44 AM
Sunshine Biopharma Inc. (Filer)
Sunshine Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/10/2024
3:26 PM
Sunshine Biopharma Inc. (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:28 PM
ARMISTICE CAPITAL, LLC (Filed by)
Sunshine Biopharma Inc. (Subject)
Sunshine Biopharma (Subject)
Form SC 13G/A
11/12/2024
10:29 AM
Sunshine Biopharma Inc. (Filer)
Sunshine Biopharma (Filer)
Form 424B4
11/07/2024
3:40 PM
Sunshine Biopharma Inc. (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
12:43 PM
Sunshine Biopharma Inc. (Filer)
Sunshine Biopharma (Filer)
Form POS AM
11/05/2024
3:05 PM
Sunshine Biopharma Inc. (Filer)
Sunshine Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2024
3:05 PM
Sunshine Biopharma Inc. (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:05 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
3:05 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
4:00 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/20/2024
2:34 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
9:40 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form NT 10-Q
05/06/2024
11:14 AM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:05 PM
Sunshine Biopharma, Inc (Filer)
Sunshine Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:SBFMW) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners